Curatis Holding AG (CHIX:CURNZ) Equity-to-Asset : -2.60 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Curatis Holding AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was CHF-0.31 Mil. Curatis Holding AG's Total Assets for the quarter that ended in Dec. 2023 was CHF0.12 Mil.

The historical rank and industry rank for Curatis Holding AG's Equity-to-Asset or its related term are showing as below:

CHIX:CURNz' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.94 Med: -2.6 Max: 0.48
Current: -2.6

During the past 3 years, the highest Equity to Asset Ratio of Curatis Holding AG was 0.48. The lowest was -2.94. And the median was -2.60.

CHIX:CURNz's Equity-to-Asset is ranked worse than
95.76% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs CHIX:CURNz: -2.60

Curatis Holding AG Equity-to-Asset Historical Data

The historical data trend for Curatis Holding AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Equity-to-Asset Chart

Curatis Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

Equity-to-Asset

-2.94

0.48

-2.60

Curatis Holding AG Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			-2.94	0.67	0.48	0.51	-2.60

Competitive Comparison of Curatis Holding AG's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curatis Holding AG's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Equity-to-Asset falls into.

Curatis Holding AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Curatis Holding AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-0.312	/	0.12
	=

Curatis Holding AG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-0.312	/	0.12
	=

Curatis Holding AG (CHIX:CURNz) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Curatis Holding AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG (CHIX:CURNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

CURN:Switzerland

Address

Hochbergerstrasse 60C, Technologiepark Basel, Basel, CHE, 4057

Website

https://www.kinarus.com

Kinarus Therapeutics Holding AG In Liquidation Formerly Kinarus Therapeutics Holding AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's therapeutic drug candidate, KIN001, consists of a clinical-stage p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, combined with a marketed drug, together enabling an oral, long-term effective treatment for patients suffering from diseases with serious impact on quality of life.

Curatis Holding AG (CHIX:CURNZ) Headlines

No Headlines